Cisplatin v cetuximab for HPV associated oropharyngeal cancer

Bookmark and Share
Published: 22 Oct 2018
Views: 446
Rating:
Save
Prof Hisham Mehanna - University of Birmingham , Birmingham, UK

Prof Hisham Mehanna presents results at ESMO 2018 in Munich comparing the outcomes of treating patients with HPV associated throat cancer with either cetuximab or cisplatin alongside radical radiotherapy.

For more on these results, watch his interview with ecancer.